ReviewJournal of robotic surgery2026
From scalpel to robot: evolution and outlook of oncologic robotic surgery in Colombia.
Review in Journal of robotic surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionRobotic surgery has transformed the management of oncologic pathologies by offering minimally invasive approaches with improved precision and outcomes. In Colombia, despite its progressive adoption, the scientific literature remains scarce, limiting comprehensive evaluation of its national impact.
objectiveTo analyze the evolution, current status, and future perspectives of robotic surgery in oncology within Colombia, emphasizing its clinical benefits, technological milestones, limitations, and integration with artificial intelligence.
methodsA narrative review was conducted using national and international databases. Articles published between 2014 and 2025 concerning robotic surgery in Colombia-with a focus on oncologic applications-were included.
resultshe review identified multiple national milestones that mark Colombia's gradual integration of robotic surgery into oncologic practice. Notably, the first documented use of the da Vinci
conclusionsDespite limited publications, current Colombian evidence supports the feasibility, safety, and oncologic effectiveness of robotic surgery. The future of oncologic care in the country hinges on sustained investment, training, and the incorporation of AI-driven innovations to democratize access and optimize outcomes in complex surgical oncology.
Indexed as
Identifiers
41748797What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.